Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03303339
Title PCM-075 in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Trovagene, Inc.
Indications

acute myeloid leukemia

Therapies

Decitabine + Onvansertib

Cytarabine + Decitabine + Onvansertib

Cytarabine + Onvansertib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.